From: A pilot feasibility study of gabapentin for managing pain in children with dystonic cerebral palsy
Outcome measure | BaselineMean (SD) | 6 weeksMean (SD) | 12 weeksMean (SD) | Difference from baseline at 12 weeksMean 95 % (CI) |
---|---|---|---|---|
COPM performance | 3.6 (0.9) N = 12 | Not collected | 7.0 (1.4) N = 11 | 3.5 (2.3, 4.6) |
COPM satisfaction | 2.2 (0.9) N = 12 | Not collected | 7.2 (2.6) N = 11 | 4.8 (3.1, 6.6) |
BADS | 23.8 (4.3) N = 12 | 20.9 (6.4) N = 10 | 21.9 (3.8) N = 10 | -1.4 (-3.6, 0.8) |
FPS-R | 2.8 (1.4) N = 12 | 1.5 (1.3) N = 12 | 1.0 (1.3) N = 10 | -1.8 (-3.1, -0.5) |
CPCHILD | ||||
Personal care | 36.7 (20.3) N = 13 | 52.9 (22.3) N = 7 | 49.4 (18.2) N = 11 | 10.3 (2.0, 18.6) |
Positioning/transferring/mobility | 38.8 (19.7) N = 13 | 53.0 (16.8) N = 7 | 51.4 (17.9) N = 11 | 8.3 (-4.9, 21.6) |
Comfort & emotions | 62.4 (23.4) N = 13 | 78.9 (14.8) N = 7 | 81.2 (12.4) N = 11 | 11.1 (1.5, 20.8) |
Communication/social interaction | 54.6 (17.0) N = 13 | 72.1 (16.7) N = 7 | 70.0 (14.3) N-11 | 13.0 (2.6, 23.4) |
Health | 64.6 (17.7) N = 13 | 60.0 (13.9) N = 7 | 73.9 (11.7) N = 11 | 6.7 (-2.7, 16.1) |
Overall QoL | 67.7 (27.7) N = 13 | 80.0 (17.9) N = 7 | 70.9 (16.4) N = 11 | 0.0 (-6.0, 6.0) |
Total | 54.1 (16.6) N = 13 | 65.5 (14.0) N = 7 | 66.1 (11.7) N = 11 | 8.2 (0.9, 15.6) |
CCHQ | ||||
Personal care | 4.1 (1.2) N = 13 | 2.6 (1.5) N = 6 | 3.2 (1.3) N = 11 | -0.8 (-1.7, 0.10) |
Positioning/transferring | 3.9 (1.6) N = 13 | 2.3 (1.3) N = 6 | 2.5 (1.1) N = 11 | -1.1 (-2.2, -0.10) |
Comfort | 3.6 (1.2) N = 13 | 2.7 (1.4) N = 6 | 2.5 (1.5) N = 11 | -0.9 (-1.6, -0.20) |
Interaction/communication | 3.3 (1.1) N = 13 | 2.5 (0.9) N = 6 | 2.8 (1.1) N = 11 | -0.5 (-0.9, -0.10) |